Cargando…
Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
OBJECTIVES: Concerns have been raised about a possible link between bisphosphonate use, and in particular alendronate, and upper gastrointestinal (UGI) cancer. A number of epidemiological studies have been published with conflicting results. We conducted a systematic review and meta-analysis of obse...
Autores principales: | Wright, Ellen, Schofield, Peter T, Molokhia, Mariam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680000/ https://www.ncbi.nlm.nih.gov/pubmed/26644118 http://dx.doi.org/10.1136/bmjopen-2014-007133 |
Ejemplares similares
-
Bisphosphonates and Risk of Upper Gastrointestinal Cancer — A Case Control Study Using the General Practice Research Database (GPRD)
por: Wright, Ellen, et al.
Publicado: (2012) -
Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case–control study
por: Erviti, Juan, et al.
Publicado: (2013) -
Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case–control study
por: Erviti, Juan, et al.
Publicado: (2013) -
Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis
por: Kulkarni, Spoorthy, et al.
Publicado: (2022) -
Multiple Myeloma and the Role of Bisphosphonates in Its Management
por: Tanveer, Nida, et al.
Publicado: (2023)